{
  "source_pdf": "data/clinical_files/Treanor et al. (2011).pdf",
  "blocks": [
    {
      "id": "e126e7cc",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        1331.34716796875,
        2364.89111328125,
        2390.693115234375,
        3037.227783203125
      ],
      "text": "ruses\n that\n might\n also\n be\n responsible\n for\n pandemic\n inﬂuenza.\n It\n is\nsually\n necessary\n to\n adapt\n candidate\n vaccine\n viruses\n for\n high\n yield\nrowth\n in\n eggs,\n a\n process\n that\n can\n be\n time\n consuming,\n is\n not\n always\nuccessful,\n and\n which\n can\n select\n receptor\n variants\n that\n may\n not\n be\nptimally\n representative\n of\n circulating\n inﬂuenza\n strains\n [1,2].\nExpression\n of\n proteins\n in\n insect\n cells\n using\n recombinant\n bac-\novirus\n has\n emerged\n as\n a\n promising\n technology\n for\n vaccine\nroduction.\n New\n recombinant\n baculoviruses\n can\n be\n generated\nuickly\n from\n sequence\n data,\n protein\n expression\n is\n very\n efﬁcient\nnder\n the\n control\n of\n the\n baculovirus\n polyhedrin\n promoter,\n and\n post\nanslational\n modiﬁcations\n of\n the\n protein\n are\n generally\n similar\n to\nther\n eukaryotic\n systems.\n In\n previous\n studies,\n we\n have\n evaluated\naculovirus-expressed\n recombinant\n inﬂuenza\n virus\n hemagglu-\nnins\n (rHA0s)\n as\n inﬂuenza\n vaccines\n in\n humans.\n Monovalent\n and\nvalent\n rHA0s\n have\n been\n well\n tolerated\n and\n immunogenic\n in",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9973111152648926,
        "detection_dpi": 300
      }
    },
    {
      "id": "e895b74d",
      "page_index": 0,
      "role": "Figure",
      "bbox": [
        222.56666564941406,
        268.39971923828125,
        2351.02880859375,
        581.3436279296875
      ],
      "text": "[FIGURE 1 - See figure_p1_e895b74d.png]",
      "html": null,
      "image_path": "figures/figure_p1_e895b74d.png",
      "metadata": {
        "score": 0.9776971340179443,
        "detection_dpi": 300
      }
    },
    {
      "id": "eecb34ce",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        212.1886444091797,
        2455.18505859375,
        1263.8031005859375,
        2732.85400390625
      ],
      "text": "Although\n embryonated\n hen s\n eggs\n have\n been\n used\n to\n generate\nfective\n inﬂuenza\n vaccines\n for\n many\n years,\n this\n system\n does\n have\nveral\n important\n drawbacks.\n Vaccine\n manufacturing\n using\n eggs\nquires\n specialized\n facilities,\n and\n the\n ability\n to\n scale\n up\n egg\n pro-\nuction\n rapidly\n in\n response\n to\n an\n emergency\n is\n limited.\n In\n addition,\noultry\n are\n potentially\n vulnerable\n to\n the\n same\n subtypes\n of\n inﬂuenza",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9937705397605896,
        "detection_dpi": 300
      }
    },
    {
      "id": "8f330827",
      "page_index": 0,
      "role": "Title",
      "bbox": [
        162.76983642578125,
        726.2423706054688,
        2363.09716796875,
        879.16064453125
      ],
      "text": "Protective\n efﬁcacy\n of\n a\n trivalent\n recombinant\n hemagglutinin\n protein\n vaccine\n(FluBlok®)\n against\n inﬂuenza\n in\n healthy\n adults:\n A\n randomized,\n placebo-controlled\ntrial\u0002",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9837835431098938,
        "detection_dpi": 300
      }
    },
    {
      "id": "18697bc8",
      "page_index": 0,
      "role": "Title",
      "bbox": [
        212.52365112304688,
        2373.4287109375,
        477.9374084472656,
        2417.881103515625
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.99134361743927,
        "detection_dpi": 300
      }
    },
    {
      "id": "041d051e",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        917.1945190429688,
        1925.26318359375,
        2384.979248046875,
        2196.996826171875
      ],
      "text": "sults:\n Rates  of local  and  systemic\n side  effects  were  low,  and  the  rates  of systemic\n side  effects\n were\nmilar\n in the  vaccine\n and  placebo\n groups.\n HAI  antibody\n responses\n were  seen\n in  78%,  81%,  and  52%  of\nBlok\n recipients\n to  the  H1,  H3,  and  B  components,\n respectively.\n FluBlok\n was\n 44.6%  (95% CI, 18.8%,\n6%)\n effective  in  preventing\n culture-conﬁrmed\n inﬂuenza\n meeting\n the  CDC  inﬂuenza-like  illness  case\nﬁnition\n despite\n signiﬁcant\n antigenic\n mismatch\n between\n the  vaccine\n antigens\n and\n circulating\n viruses.\nnclusions:\n Trivalent\n rHA0\n vaccine\n was  safe,  immunogenic\n and  effective  in  the  prevention\n of  culture\nnﬁrmed\n inﬂuenza\n illness,\n including\n protection\n against  drift  variants.\n© 2011 Elsevier Ltd All rights reserved",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9484871029853821,
        "detection_dpi": 300
      }
    },
    {
      "id": "6568da35",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        924.4695434570312,
        1531.66748046875,
        2385.689453125,
        1917.672607421875
      ],
      "text": "g\np\ny\ngg\ncine\n production\n is  a high  priority.\n We  conducted\n this  study\n to determine\n the  protective\n efﬁcacy\n a\nombinant,\n baculovirus-expressed\n seasonal\n trivalent\n inﬂuenza\n virus  hemagglutinin\n (rHA0)\n vaccine\nuBlok®).\nthods:\n Healthy\n adult  subjects\n at 24  centers\n across\n the  US\n were  randomly\n assigned\n to  receive  a single\nection\n of saline  placebo\n (2304  subjects),\n or trivalent\n FluBlok\n containing\n 45  mcg  of  each\n rHA0  component\n44\n subjects).\n Serum  samples\n for  assessment\n of  immune\n responses\n by  hemagglutination-inhibition\nAI)\n were  taken  from  a subset  of subjects\n before\n and 28  days  after  immunization.\n Subjects  were\n followed\ning\n the  2007–2008\n inﬂuenza\n season\n and  combined\n nasal  and  throat  swabs\n for  virus  isolation\n were\nained\n from  subjects\n reporting\n inﬂuenza-like\n illness.\nults: Rates of local and systemic side effects were low and the rates of systemic side effects were",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9026379585266113,
        "detection_dpi": 300
      }
    },
    {
      "id": "393e8d7c",
      "page_index": 0,
      "role": "Title",
      "bbox": [
        906.5031127929688,
        1451.8878173828125,
        1181.7774658203125,
        1491.568115234375
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.958551824092865,
        "detection_dpi": 300
      }
    },
    {
      "id": "0a86f0f1",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        209.3236083984375,
        2856.49169921875,
        1260.949462890625,
        3029.251220703125
      ],
      "text": "∗Corresponding\n author\n at:\n University\n of\n Rochester\n Medical\n Center,\n Room\n 3-6308,\n1\n Elmwood\n Avenue,\n Rochester,\n NY\n 14642,\n United\n States.\n Tel.:\n +1\n 585\n 275\n 5871;\nx:\n +1\n 585\n 442\n 9328.\nE-mail\n address:\n John Treanor@urmc.rochester.edu\n (J.J.\n Treanor).",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9340471029281616,
        "detection_dpi": 300
      }
    },
    {
      "id": "d565acf9",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        212.62741088867188,
        1091.333984375,
        960.5818481445312,
        1354.06201171875
      ],
      "text": "University\n of\n Rochester,\n Rochester,\n NY,\n United\n States\naylor\n College\n of\n Medicine,\n Houston,\n TX,\n United\n States\nUniversity\n of\n Maryland,\n Baltimore,\n MD,\n United\n States\nt.\n Louis\n University,\n St.\n Louis,\n MO,\n United\n States\nrotein\n Sciences\n Corporation,\n Meriden,\n CT,\n United\n States\nlair\n &\n Co,\n Greenwich,\n CT,\n United\n States\niologics\n Consulting\n Group,\n Inc.,\n Bethesda,\n MD,\n United\n States",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.8091946840286255,
        "detection_dpi": 300
      }
    },
    {
      "id": "776faf31",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        244.9888458251953,
        972.0548095703125,
        2274.195068359375,
        1065.392333984375
      ],
      "text": "n\n J.\n Treanor\n,  Hana\n El  Sahly , James\n King ,  Irene\n Graham ,  Ruvim\n Izikson ,  Robert\n Kohberger ,\ner  Patriarca g, Manon\n Cox e",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.8090948462486267,
        "detection_dpi": 300
      }
    },
    {
      "id": "6d743ec2",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        215.3678436279297,
        3065.023193359375,
        1126.4710693359375,
        3137.2421875
      ],
      "text": "i:10.1016/j.vaccine.2011.07.128",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.5181697607040405,
        "detection_dpi": 300
      }
    },
    {
      "id": "39d5e393",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1288.0123291015625,
        1025.2935791015625,
        2348.565185546875,
        2128.93603515625
      ],
      "text": "Sera\n from\n the\n immunogenicity\n subset\n were\n assessed\n for\nntibody\n to\n each\n of\n the\n three\n components\n of\n the\n vaccine\n by\nemagglutination-inhibition\n (HAI)\n at\n the\n Cincinnati\n Children’s\nospital\n using\n a\n validated\n assay\n based\n on\n standard\n methods.\n All\nvailable\n sera\n from\n vaccine\n recipients,\n and\n a\n randomly\n selected\nubset\n of\n approximately\n 33%\n of\n placebo\n specimens\n were\n selected\nr\n testing.\n The\n antigens\n used\n in\n the\n assays\n were\n baculovirus\nerived\n rHAs\n representing\n the\n A/Solomon\n Islands/03/2006\n (H1N1),\n/Wisconsin/67/2005\n (H3N2),\n and\n B/Malaysia/2506/2004\n viruses,\nrovided\n by\n Protein\n Sciences\n Corporation.\n Sera\n were\n treated\n with\neuraminidase\n (RDE,\n Denka-Seiken,\n Japan)\n to\n remove\n non-speciﬁc\nhibitors\n of\n hemagglutination\n prior\n to\n testing,\n and\n were\n tested\n in\nrial\n two-fold\n dilutions\n at\n an\n initial\n dilution\n of\n 1:10.\n Sera\n with\no\n reactivity\n at\n 1:10\n were\n assigned\n a\n value\n of\n 1:5.\n Assays\n were\nerformed\n using\n turkey\n red\n blood\n cells\n (Viromed\n Laboratories,\n Min-\netonka,\n MN).\nSwabs\n for\n virus\n culture\n were\n stored\n at\n −70 ◦C\n and\n shipped\n on\nry\n ice\n to\n a\n central\n laboratory\n (Cincinnati\n Children’s\n Hospital\n Med-\nal\n Center,\n Cincinnati,\n OH)\n where\n virus\n isolation\n was\n performed\n in\nrimary\n rhesus\n monkey\n kidney\n (RhMK)\n cells\n (Diagnostic\n Hybrids\nc\n (DHI),\n Athens,\n Ohio).\n The\n presence\n of\n inﬂuenza\n A\n or\n B\n viruses\nthe\n culture\n was\n determined\n by\n immunoﬂuorescence\n using\n type-\npeciﬁc\n monoclonal\n antibodies\n (DHI).\n All\n inﬂuenza\n isolates\n were\nubsequently\n subtyped\n and\n antigenically\n characterized\n based\n on\nactivity\n to\n ferret\n antiserum\n raised\n against\n WHO\n reference\n strains.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.994508683681488,
        "detection_dpi": 300
      }
    },
    {
      "id": "aaa92306",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        165.20272827148438,
        1994.3555908203125,
        1225.3900146484375,
        2912.640380859375
      ],
      "text": "The\n study\n was\n conducted\n at\n 24\n centers\n located\n across\n the\n United\nates\n (Appendix)\n during\n the\n 2007–2008\n inﬂuenza\n season.\n Subjects\nere\n healthy\n adults\n aged\n 18–49\n years\n inclusive,\n who\n did\n not\n belong\n high\n priority\n target\n groups\n for\n inﬂuenza\n vaccination\n as\n deﬁned\ny\n the\n Advisory\n Committee\n on\n Immunization\n Practice\n [10]. Women\n child-bearing\n potential\n had\n a\n negative\n urine\n pregnancy\n test\n at\nhe\n time\n of\n randomization\n and\n were\n instructed\n to\n use\n contracep-\non\n during\n the\n course\n of\n the\n study.\n After\n screening\n medical\n history\nnd\n physical\n exam\n to\n determine\n eligibility,\n subjects\n were\n randomly\nsigned\n to\n receive\n either\n a\n single\n dose\n of\n FluBlok,\n or\n saline\n placebo\nsing\n a\n permuted\n block\n randomization\n scheme\n stratiﬁed\n for\n each\nudy\n site.\n Vaccine\n was\n administered\n as\n a\n single\n intramuscular\njection\n in\n the\n upper\n deltoid.\nSubjects\n measured\n their\n oral\n temperature\n daily\n and\n maintained\nmemory\n aid\n for\n 7\n days\n after\n vaccination\n on\n which\n they\n recorded\ncal\n and\n systemic\n reactions\n graded\n as\n “mild”\n (noticeable\n but\n not\nterfering\n with\n normal\n activities),\n “moderate”\n (some\n interference\nith\n normal\n activities),\n and\n “severe”\n (symptom\n prevented\n nor-\nal\n daily\n activities).\n Subjects\n received\n a\n phone\n call\n at\n day\n 7\n for\nview\n of\n the\n memory\n aid,\n concomitant\n medications\n and\n medical\nstory.\nIn addition\nsubjects from ﬁve sites (total\nN = 870) partici-",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9958437085151672,
        "detection_dpi": 300
      }
    },
    {
      "id": "4c739f9d",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1289.033935546875,
        2260.505615234375,
        2345.8681640625,
        3142.6728515625
      ],
      "text": "The\n primary\n safety\n endpoints\n for\n this\n study\n were\n the\n rates\nnd\n severity\n of\n solicited\n and\n unsolicited\n adverse\n events.\n The\n pri-\nary\n immunogenicity\n endpoints\n were\n the\n rates\n of\n 4-fold\n or\n greater\ncreases\n in\n serum\n HAI\n antibody\n to\n each\n of\n the\n three\n vaccine\nrains\n comparing\n pre-\n and\n 28-day\n post-vaccination\n samples.\n The\nrimary\n efﬁcacy\n endpoint\n was\n culture-documented\n inﬂuenza\n ill-\ness,\n deﬁned\n as\n development\n of\n a\n CDC-deﬁned\n inﬂuenza-like\nness\n (CDC-ILI)\n associated\n with\n recovery\n of\n inﬂuenza\n virus\n from\nnasopharyngeal\n swab.\n CDC-ILI\n was\n deﬁned\n as\n the\n presence\n of\nocumented\n fever\n ≥100\n F\n plus\n either\n sore\n throat\n or\n cough.\nSafety\n of\n the\n rHA0\n vaccine\n was\n evaluated\n via\n the\n frequencies\nnd\n percentages\n of\n subjects\n experiencing\n adverse\n events,\n and\n a\nhi-squared\n test\n at\n a\n nominal\n 0.05\n level\n was\n performed\n to\n ﬁnd\nny\n differences\n in\n incidence\n rates\n between\n groups.\n Differences\netween\n groups\n in\n the\n proportions\n of\n subjects\n with\n at\n least\n a\n four-\nld\n increase\n in\n HAI\n antibody\n were\n also\n tested\n using\n a\n Chi-Square\nst.\n Protective\n efﬁcacy\n (PE)\n was\n calculated\n as\n (1-RR),\n where\n RR\n is\ne\n relative\n risk\n of\n having\n an\n event\n compared\n to\n the\n placebo\n group.\npper\n and\n lower\n conﬁdence\n limits\n for\n the\n RR\n were\n calculated\n using\ne\n exact\n conditional\n binomial\n procedure.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9967708587646484,
        "detection_dpi": 300
      }
    },
    {
      "id": "57b7169e",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        166.09091186523438,
        1063.789306640625,
        1217.337646484375,
        1842.495361328125
      ],
      "text": "The\n vaccine\n (FluBlok)\n used\n in\n this\n study\n consisted\n of\n puri\ned\n hemagglutinin\n (HA)\n proteins\n produced\n in\n insect\n cells\n using\nbaculovirus\n expression\n system\n as\n previously\n described\n [9].  The\ncombinant\n HA\n protein\n is\n not\n cleaved\n in\n insect\n cells\n and\n is\nferred\n to\n as\n rHA0.\n The\n trivalent\n vaccine\n contained\n 45\n mcg\ns\n measured\n by\n the\n single\n radial\n immunodiffusion\n assay)\n of\nach\n puriﬁed\n rHA0\n derived\n from\n the\n A/Solomon\n Islands/3/2006\nH1N1),\n A/Wisconsin/67/2005\n (H3N2),\n and\n B/Malaysia/2506/2004\nﬂuenza\n viruses\n recommended\n for\n the\n 2007–2008\n inﬂuenza\nason\n formulated\n with\n 0.005%\n Tween®-20\n in\n 10\n mM sodium\nhosphate\n buffer\n pH\n 7.0\n ±\n 0.4\n without\n a\n preservative.\n Genes\nere\n cloned\n into\n baculovirus\n using\n RT-PCR\n from\n the\n same\n CDC-\nerived\n vaccine\n seed\n viruses\n used\n for\n the\n production\n of\n licensed\nactivated\n inﬂuenza\n vaccine\n for\n that\n year.\n Sodium\n dodecyl\n sulfate-\nolyacrylamide\n gel\n electrophoresis\n of\n the\n puriﬁed\n monovalent\naterials\n indicated\n that\n hemagglutinin\n constitutes\n at\n least\n 90%\n of\ne\n total\n protein.\n Placebo\n consisted\n of\n normal\n saline\n for\n injection,\nSP.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9903689026832581,
        "detection_dpi": 300
      }
    },
    {
      "id": "b1cafa15",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        162.28414916992188,
        259.2691345214844,
        1233.3082275390625,
        834.04736328125
      ],
      "text": "oung\n adults\n and\n adults\n 65\n and\n older\n [3 5].\n More\n recent\n stud\ns\n have\n evaluated\n rHA0\n vaccine\n formulations\n in\n healthy\n adults,\nubjects\n aged\n 50–64\n years\n of\n age\n [6]\n and\n subjects\n 65\n and\n older\n7,8].\n These\n studies\n have\n consistently\n shown\n excellent\n tolerabil-\ny\n and\n antibody\n responses\n similar\n to\n those\n seen\n with\n egg-derived\nnﬂuenza\n vaccines.\n Finally,\n in\n a\n preliminary\n ﬁeld\n efﬁcacy\n eval-\nation,\n recipients\n of\n the\n rHA0\n vaccine\n had\n reduced\n rates\n of\nulture-positive\n CDC-deﬁned\n inﬂuenza-like\n illness\n compared\n with\nlacebo\n recipients,\n although\n the\n study\n was\n small\n [9].\nIn\n the\n present\n study,\n we\n performed\n a\n much\n larger\n assessment\nf\n the\n immunogenicity,\n safety,\n and\n protective\n efﬁcacy\n of\n the\n ﬁnal\normulation\n of\n trivalent\n rHA0\n vaccine\n in\n a\n population\n of\n healthy\noung\n adults.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9948445558547974,
        "detection_dpi": 300
      }
    },
    {
      "id": "e0130593",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1286.5679931640625,
        489.063232421875,
        2354.124267578125,
        893.136962890625
      ],
      "text": "During\n the\n inﬂuenza\n season,\n subjects\n completed\n a\n weekly\n diary\no\n record\n inﬂuenza\n symptoms,\n and\n after\n inﬂuenza\n was\n recognized\n the\n community,\n subjects\n received\n weekly\n phone\n calls\n to\n review\nhe\n diary\n and\n ascertain\n the\n presence\n or\n absence\n of\n respiratory\n ill-\ness\n symptoms.\n Subjects\n were\n instructed\n to\n return\n to\n the\n clinic\n for\nness\n evaluations\n if\n they\n observed\n any\n acute\n respiratory\n symp-\noms\n or\n fever.\n During\n these\n illness\n visits,\n symptoms\n were\n reviewed,\nbrief\n physical\n exam\n was\n conducted,\n and\n combined\n nasal\n and\nhroat\n swabs\n for\n virus\n culture\n were\n obtained.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9841086268424988,
        "detection_dpi": 300
      }
    },
    {
      "id": "bd12cc22",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        172.0801544189453,
        2918.431884765625,
        1215.845458984375,
        3144.3798828125
      ],
      "text": "In\n addition,\n subjects\n from\n ﬁve\n sites\n (total,\n N\n \n 870)\n partici\nted\n in\n a\n serological\n substudy.\n At\n these\n sites,\n subjects\n had\n serum\ntained\n prior\n to\n vaccination,\n and\n returned\n approximately\n 28\n days\nter\n vaccination\n for\n assessment\n of\n serum\n antibody\n to\n inﬂuenza\nrus.\n All\n other\n subjects\n received\n a\n phone\n call\n from\n their\n medical",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9950025677680969,
        "detection_dpi": 300
      }
    },
    {
      "id": "9bd380aa",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        168.5828857421875,
        896.5446166992188,
        365.19525146484375,
        940.0370483398438
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9917606115341187,
        "detection_dpi": 300
      }
    },
    {
      "id": "07b850a1",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        1287.8238525390625,
        2182.96826171875,
        1656.571044921875,
        2225.406982421875
      ],
      "text": "y",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9904850721359253,
        "detection_dpi": 300
      }
    },
    {
      "id": "253719be",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        1285.8465576171875,
        409.51055908203125,
        1754.5772705078125,
        453.37451171875
      ],
      "text": "f\nﬂ",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9892852902412415,
        "detection_dpi": 300
      }
    },
    {
      "id": "01e433fe",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        1286.507568359375,
        949.076416015625,
        1639.068359375,
        990.920166015625
      ],
      "text": "y\ny",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9873510003089905,
        "detection_dpi": 300
      }
    },
    {
      "id": "6407097a",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        163.03269958496094,
        986.4230346679688,
        361.9392395019531,
        1027.6202392578125
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9879021644592285,
        "detection_dpi": 300
      }
    },
    {
      "id": "081c4cc9",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        164.38552856445312,
        1919.095947265625,
        551.3839111328125,
        1963.0418701171875
      ],
      "text": "y\ng",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9848639369010925,
        "detection_dpi": 300
      }
    },
    {
      "id": "c767ff20",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1278.916259765625,
        263.53076171875,
        2343.79150390625,
        349.1513977050781
      ],
      "text": "y\ny\np\nccurred\n at\n the\n end\n of\n the\n inﬂuenza\n season.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9286318421363831,
        "detection_dpi": 300
      }
    },
    {
      "id": "83dd9191",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        1335.366455078125,
        1879.7567138671875,
        2385.973388671875,
        3118.248291015625
      ],
      "text": "ported\n by\n subjects\n in\n the\n 7\n days\n following\n administration\n of\nuBlok\n or\n placebo\n are\n shown\n in\n Table\n 1.\n FluBlok\n was\n associated\nith\n local\n injection\n site\n pain\n and\n muscle\n aches\n that\n were\n signif-\nantly\n more\n frequent\n than\n after\n saline\n placebo\n (P\n < .03\n for\n pain).\nowever,\n 94%\n of\n all\n complaints\n of\n pain\n after\n FluBlok\n were\n rated\nmild.\n Systemic\n symptoms\n following\n vaccination\n did\n not\n occur\nsigniﬁcantly\n different\n rates\n in\n vaccine\n and\n placebo\n recipients\n>\n .05\n for\n all\n comparisons).\n The\n most\n frequently\n reported\n sys-\nmic\n symptoms\n following\n vaccination\n were\n headache\n (15%\n in\n both\noups)\n and\n fatigue\n or\n lack\n of\n energy\n (14.5%\n in\n both\n groups).\n The\najority\n (76%)\n of\n complaints\n of\n headache\n were\n also\n mild.\n There\nere\n 17\n reports\n of\n fever\n (oral\n temperature\n >100.4\n F)\n among\n FluBlok\ncipients\n and\n 12\n among\n placebo\n recipients\n following\n vaccination.\nThere\n were\n 85\n severe\n adverse\n events\n (SAEs)\n reported\n during\n the\nudy\n in\n 64\n subjects.\n Of\n these,\n 41\n SAEs\n were\n reported\n in\n 30\n subjects\n.28%)\n in\n the\n FluBlok\n group,\n and\n 44\n SAEs\n in\n 34\n subjects\n (1.48%)\nthe\n placebo\n group.\n Two\n subjects\n died\n during\n the\n study;\n one\n in\nach\n group.\n A\n subject\n in\n the\n FluBlok-treatment\n group\n experienced\n a\ntal\n pulmonary\n embolism\n approximately\n three\n months\n post\n vacci-\nation,\n and\n a\n subject\n in\n the\n placebo\n group\n had\n a\n fatal\n motor\n vehicle\ncident.\n Both\n deaths\n were\n considered\n to\n be\n unrelated\n to\n the\n study\ny\n the\n site\n investigator.\n All\n but\n two\n SAEs\n (a\n liposarcoma\n in\n a\n FluBlok\ncipient\n and\n breast\n cancer\n in\n a\n placebo\n recipient)\n had\n resolved\ny\n the\n end\n of\n the\n study\n period.\n None\n of\n the\n 85\n SAEs\n in\n the\n study\nere\n considered\n to\n be\n deﬁnitely\n or\n probably\n related\n to\n vaccine.\n One\nvent,\n a\n pericardial\n effusion\n in\n a\n FluBlok\n recipient\n was\n judged\n to\n be\nossibly\n related\n to\n vaccine.\n This\n event\n occurred\n in\n a\n 47\n year-old\nale\n with\n a\n prior\n history\n of\n hypertension,\n who\n began\n experiencing",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.974348783493042,
        "detection_dpi": 300
      }
    },
    {
      "id": "5bbb19f2",
      "page_index": 2,
      "role": "Table",
      "bbox": [
        211.55128479003906,
        353.47906494140625,
        2405.286865234375,
        902.7745361328125
      ],
      "text": "[TABLE 3 - See table_p3_5bbb19f2.png]",
      "html": null,
      "image_path": "figures/table_p3_5bbb19f2.png",
      "metadata": {
        "score": 0.9811446070671082,
        "detection_dpi": 300
      }
    },
    {
      "id": "e24f87e5",
      "page_index": 2,
      "role": "Figure",
      "bbox": [
        228.98492431640625,
        2070.308349609375,
        1255.3172607421875,
        3067.834716796875
      ],
      "text": "[FIGURE 10 - See figure_p3_e24f87e5.png]",
      "html": null,
      "image_path": "figures/figure_p3_e24f87e5.png",
      "metadata": {
        "score": 0.996523916721344,
        "detection_dpi": 300
      }
    },
    {
      "id": "fda05911",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        1335.154541015625,
        1068.440673828125,
        2391.016357421875,
        1728.40234375
      ],
      "text": "ceive\n FluBlok\n and\n 2304\n were\n randomized\n to\n placebo.\n The\n major\ny\n of\n subjects\n were\n white\n (66%)\n and\n female\n (59%).\n The\n mean\n age\nas\n 32.5\n years.\n Three\n subjects\n were\n over\n the\n enrollment\n criteria\n of\n9\n years\n or\n less,\n so\n that\n the\n age\n range\n enrolled\n was\n 18–55\n years;\nese\n three\n subjects\n are\n included\n in\n both\n the\n safety\n and\n efﬁcacy\nnalyses.\n There\n were\n no\n differences\n with\n respect\n to\n age,\n sex\n or\n race\netween\n the\n groups.\nThere\n were\n 577\n subjects\n who\n did\n not\n complete\n the\n study,\n the\najority\n of\n whom\n were\n lost\n to\n follow-up\n (260\n (11%)\n in\n the\n FluBlok\nnd\n 251\n (11%)\n in\n the\n placebo\n group).\n In\n addition,\n 36\n subjects\nithdrew\n consent\n (22\n (1%)\n and\n 14\n (0.6%)\n in\n FluBlok\n and\n placebo,\nspectively),\n 3\n in\n each\n group\n withdrew\n due\n to\n an\n adverse\n event\nAE),\n there\n was\n 1\n death\n in\n each\n group,\n and\n 9\n and\n 13\n subjects\n in\ne\n FluBlok\n and\n placebo\n groups,\n respectively\n were\n discontinued\n for\nher\n reasons.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9954291582107544,
        "detection_dpi": 300
      }
    },
    {
      "id": "718e89cb",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        216.24618530273438,
        1070.7744140625,
        1266.5472412109375,
        1381.3770751953125
      ],
      "text": "p\ny\np\non\n that\n FluBlok\n would\n be\n at\n least\n 70%\n efﬁcacious\n in\n prevention\n of\nmptomatic,\n culture-proven\n inﬂuenza,\n and\n that\n the\n placebo\n attack\nte\n would\n be\n 3%\n or\n greater.\n The\n sample\n size\n was\n then\n chosen\n to\nve\n 80%\n power\n to\n determine\n that\n the\n lower\n bound\n of\n the\n 95%\nnﬁdence\n interval\n for\n protective\n efﬁcacy\n was\n greater\n than\n 40%,\nsuming\n a\n 5%\n attrition\n rate.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9913195967674255,
        "detection_dpi": 300
      }
    },
    {
      "id": "c712d5fe",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        204.66954040527344,
        903.4017944335938,
        2420.568115234375,
        1009.1325073242188
      ],
      "text": "nd\n 3\n =\n severe,\n prevents\n normal\n daily\n activity.\n* P\n <\n .05\n compared\n to\n placebo.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9908060431480408,
        "detection_dpi": 300
      }
    },
    {
      "id": "8a2a1e60",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        221.5938262939453,
        295.4809875488281,
        1370.252197265625,
        334.05072021484375
      ],
      "text": "mptoms\nNo (%) of subjects\nith complaints b\nle el of se eri",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9968671202659607,
        "detection_dpi": 300
      }
    },
    {
      "id": "0d504bc4",
      "page_index": 2,
      "role": "Title",
      "bbox": [
        210.54530334472656,
        1745.21826171875,
        386.1953125,
        1788.923095703125
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9949136972427368,
        "detection_dpi": 300
      }
    },
    {
      "id": "9fb6598a",
      "page_index": 2,
      "role": "Title",
      "bbox": [
        1334.118408203125,
        1791.6148681640625,
        1845.6640625,
        1833.232666015625
      ],
      "text": "f\nf\ny",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9900683760643005,
        "detection_dpi": 300
      }
    },
    {
      "id": "8051b61b",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        219.4615478515625,
        1828.6318359375,
        1262.4434814453125,
        2012.710205078125
      ],
      "text": "tota o\n6 8 e g b e subjects\ne e a do\ned\n:\nto ece\ne\nher\n FluBlok\n or\n Placebo,\n and\n 4071\n (87.5%)\n completed\n all\n study\nocedures.\n The\n disposition\n of\n the\n study\n subjects\n is\n shown\n in\ng.\n 1.\n Of\n the\n 4648\n enrolled\n subjects,\n 2344\n were\n randomized\n to",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9716306328773499,
        "detection_dpi": 300
      }
    },
    {
      "id": "402f2b92",
      "page_index": 2,
      "role": "Title",
      "bbox": [
        210.31634521484375,
        1432.084716796875,
        556.0889282226562,
        1474.6640625
      ],
      "text": "f",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9867922067642212,
        "detection_dpi": 300
      }
    },
    {
      "id": "75d5bc70",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        226.08775329589844,
        1514.1650390625,
        1270.3875732421875,
        1692.8935546875
      ],
      "text": "j\ne\n study,\n and\n the\n study\n was\n approved\n by\n the\n institutional\n review\nards\n at\n each\n study\n site\n prior\n to\n initiation\n of\n the\n study\n and\n enroll-\nent\n of\n subjects.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9683697819709778,
        "detection_dpi": 300
      }
    },
    {
      "id": "6a79c2aa",
      "page_index": 2,
      "role": "Title",
      "bbox": [
        213.63082885742188,
        262.5779724121094,
        304.8411865234375,
        293.43743896484375
      ],
      "text": "tes\n of\n lo",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9768865704536438,
        "detection_dpi": 300
      }
    },
    {
      "id": "9e027617",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        387.0970764160156,
        3096.448486328125,
        1090.9237060546875,
        3132.680908203125
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9524081349372864,
        "detection_dpi": 300
      }
    },
    {
      "id": "12d470c9",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        1282.06494140625,
        1000.5797119140625,
        2346.513427734375,
        3138.4580078125
      ],
      "text": "p\ny\np\nDC-ILI,\n and\n we\n also\n assessed\n the\n effect\n of\n vaccination\n on\n rates\n of\nny\n inﬂuenza\n culture\n positive\n illness.\nA total\n of\n 582\n subjects\n were\n cultured\n for\n respiratory\n illness,\n and\nnﬂuenza\n virus\n was\n isolated\n from\n 178\n subjects.\n There\n were\n a\n total\nf\n 120\n subjects\n from\n whom\n inﬂuenza\n A\n was\n isolated,\n the\n majority\nf\n whom\n (82/120,\n 68%)\n met\n the\n CDC-ILI\n case\n deﬁnition.\n There\n were\ntotal\n of\n 59\n subjects\n with\n positive\n cultures\n for\n inﬂuenza\n B,\n and\n the\nmajority\n of\n these\n subjects\n (41/59,\n 69%)\n also\n met\n the\n CDC-ILI\n case\neﬁnition.\nOnly\n 8\n isolates\n in\n the\n study\n (<5%\n of\n the\n total)\n were\n antigeni-\nally\n identical\n to\n the\n strains\n contained\n in\n the\n vaccine.\n All\n of\n these\niruses\n were\n A/Wisconsin/67/2005-like\n H3N2\n viruses.\n Two\n of\n these\nccurred\n in\n FluBlok\n recipients\n and\n 6\n occurred\n in\n placebo\n recipi-\nnts,\n and\n among\n these\n subjects\n one\n FluBlok\n recipient\n and\n 5\n placebo\necipients\n met\n the\n CDC-ILI\n deﬁnition.\n Therefore,\n we\n were\n unable\no\n obtain\n a\n meaningful\n estimate\n of\n the\n efﬁcacy\n of\n FluBlok\n against\nDC-ILI\n due\n to\n strains\n represented\n in\n the\n vaccine.\nThe\n remaining\n 111\n inﬂuenza\n A\n viruses\n were\n characterized\n as\nntigenic\n variants,\n i.e.,\n they\n exhibited\n a\n 4-fold\n or\n greater\n decrease\nn\n reactivity\n with\n post\n infection\n ferret\n antisera\n in\n reciprocal\n HAI\nesting.\n These\n viruses\n included\n 12\n H1N1\n viruses\n antigenically\nesembling\n H1\n drift\n variant\n A/Brisbane/59/2007,\n 41\n H3N2\n viruses\nntigenically\n resembling\n the\n H3\n drift\n variant\n A/Brisbane/10/2007,\n2\n H3N2\n viruses\n that\n could\n not\n be\n identiﬁed\n as\n either\n A/Wisconsin-\nke\n or\n A/Brisbane-like,\n and\n 16\n inﬂuenza\n viruses\n for\n which\n the\nubtype\n was\n not\n determined.\n Fifty-eight\n of\n the\n 59\n inﬂuenza\n B\niruses\n (98%)\n were\n antigenically\n similar\n to\n B/Florida/04/2006,\nepresenting\n a\n different\n clade\n from\n the\n vaccine\n strain,\n and\n one\nnﬂuenza\n B\n virus\n could\n not\n be\n antigenically\n characterized.\nThe\n cumulative\n rates\n of\n culture\n conﬁrmed\n inﬂuenza\n illness\nccurring\n in\n the\n study\n population\n over\n time\n are\n shown\n in\n Fig.\n 2,\nwhich\n shows\n that\n the\n relative\n difference\n between\n the\n two\n study\nroups\n remained\n constant\n throughout\n the\n inﬂuenza\n season.\n The\nncidence\n of\n this\n and\n of\n other\n related\n endpoints\n in\n the\n study\n by\nroup\n are\n shown\n in\n Table\n 3.\n The\n overall\n protective\n efﬁcacy\n of\nluBlok\n against\n culture\n positive\n CDC-ILI\n regardless\n of\n strain\n was\n4.6%\n (95%\n CI\n 18.8%,\n 62.6%).\n As\n expected\n given\n the\n more\n extreme\negree\n of\n antigenic\n mismatch\n for\n the\n inﬂuenza\n B\n component,\n the\nfﬁcacy\n of\n FluBlok\n was\n greater\n against\n CDC-ILI\n due\n to\n inﬂuenza\n A\niruses\n (54.4%)\n than\n inﬂuenza\n B\n viruses\n (23.1%),\n although\n the\n differ-\nnce\n was\n not\n statistically\n signiﬁcant\n (P\n =\n .20\n by\n logistic\n regression).\nowever,\n we  were\n not\n able\n to\n demonstrate\n a\n statistically\n signiﬁcant\nffect\n for\n inﬂuenza\n B.\n As\n shown\n in\n Table\n 3,\n there\n were\n no\n sub-\ntantial\n differences\n between\n the\n point\n estimates\n of\n efﬁcacy\n against\nulture\n positive\n CDC-ILI\n or\n against\n any\n culture\n positive\n illness.\n Cul-\nure\n positive\n CDC-ILI\n associated\n with\n isolation\n of\n H1N1\n viruses\nccurred\n in\n 9/2304\n placebo\n recipients\n and\n 3/2344\n FluBlok\n recip-\nents\n (PE\n =\n 67%),\n while\n culture\n positive\n CDC-ILI\n due\n to\n H3N2\n viruses",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9975330829620361,
        "detection_dpi": 300
      }
    },
    {
      "id": "eeb10c0d",
      "page_index": 3,
      "role": "Table",
      "bbox": [
        155.09165954589844,
        346.8323059082031,
        2367.777587890625,
        833.2133178710938
      ],
      "text": "[TABLE 4 - See table_p4_eeb10c0d.png]",
      "html": null,
      "image_path": "figures/table_p4_eeb10c0d.png",
      "metadata": {
        "score": 0.9956911206245422,
        "detection_dpi": 300
      }
    },
    {
      "id": "a1d79ae0",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        171.38900756835938,
        1907.3961181640625,
        1226.269287109375,
        2787.401123046875
      ],
      "text": "Serum\n HAI\n antibody\n titers\n before\n and\n after\n immunization\n in\nuBlok\n and\n placebo\n recipients\n are\n shown\n in\n Table\n 2.\n FluBlok\nduced\n serum\n antibody\n responses\n to\n all\n three\n components\n of\n the\nccine\n in\n the\n majority\n of\n recipients,\n although\n lower\n response\n rates\nere\n seen\n for\n the\n inﬂuenza\n B\n component.\n As\n expected,\n post\n vac-\nnation\n geometric\n mean\n titers\n were\n substantially\n higher\n for\n all\nree\n components\n in\n FluBlok\n than\n in\n placebo\n recipients\n (P\n <\n .001\nr\n all\n comparisons).\n The\n proportion\n of\n FluBlok\n recipients\n with\npost-vaccination\n HAI\n titer\n of\n 1:40\n or\n greater\n was\n 99%\n for\n the\n1\n component\n (95%\n CI,\n 97.1%,\n 99.5%),\n 97%\n for\n the\n H3\n component\n4.8%,\n 98.3%),\n and\n 96%\n for\n the\n B\n component\n (94.0%,\n 97.8%).\nAmong\n FluBlok\n recipients,\n subjects\n with\n a\n self-reported\n history\nseasonal\n inﬂuenza\n vaccine\n in\n the\n year\n prior\n to\n the\n study\n had\ngher\n baseline\n titers\n of\n antibody\n against\n all\n three\n components,\n and\nd\n signiﬁcantly\n lower\n frequencies\n of\n HAI\n response\n than\n did\n those\nho\n reported\n that\n they\n had\n not\n received\n vaccine\n in\n the\n previous\nar.\n Subjects\n who\n reported\n prior\n vaccine\n receipt\n also\n had\n lower\nost\n vaccination\n GMTs\n for\n all\n three\n components\n than\n did\n those\nithout\n this\n history,\n and\n this\n difference\n was\n statistically\n signiﬁcant\nr\n both\n inﬂuenza\n A\n components.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9975456595420837,
        "detection_dpi": 300
      }
    },
    {
      "id": "4073a174",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        168.38815307617188,
        1346.293212890625,
        1216.19140625,
        1792.100830078125
      ],
      "text": "e e\ne e a tota o 3\np eg a c es epo ted du\ng t e study;\n0\n in\n the\n FluBlok\n group\n and\n 17\n in\n the\n placebo\n group.\n Complete\nllow-up\n information\n was\n available\n for\n 30\n for\n them\n (15\n in\n FluBlok\nnd\n 15\n in\n placebo).\n Ten\n of\n the\n pregnancies\n among\n FluBlok\n and\n 8\nmong\n placebo\n recipients\n were\n uneventful\n and\n resulted\n in\n the\n birth\na\n normal\n infant\n at\n 36\n weeks\n gestation\n or\n later.\n Two\n women\n in\n the\nuBlok\n and\n three\n in\n the\n placebo\n group\n had\n associated\n AEs\n during\neir\n pregnancy\n which\n all\n resolved.\n Elective\n or\n spontaneous\n abor-\non\n occurred\n in\n three\n and\n four\n subjects\n in\n the\n FluBlok\n and\n placebo\noups,\n respectively.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9938194155693054,
        "detection_dpi": 300
      }
    },
    {
      "id": "e5b59852",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        157.50279235839844,
        992.1766967773438,
        1227.3922119140625,
        1345.751708984375
      ],
      "text": "ever\n and\n cough\n 7\n days\n after\n vaccination\n and\n was\n hospitalized\n 11\nays\n after\n vaccination\n with\n a\n diagnosis\n of\n pericardial\n effusion\n and\nardiac\n tamponade.\n Pericardiocentesis\n showed\n one\n colony\n of\n Propi-\nnibacterium\n spp.;\n and\n culture\n of\n pleural\n ﬂuid\n grew\n Staphylococcus\npidermidis\n only.\n Viral\n cultures\n and\n a\n panel\n of\n serum\n antibody\n tests\nor\n viruses\n causing\n pericarditis\n were\n negative.\n The\n subject\n was\n dis-\nharged\n home\n on\n Day\n 24\n following\n vaccination\n and\n the\n event\n was\nonsidered\n resolved\n by\n the\n end\n of\n the\n study\n period.\nThere were a total of 37 pregnancies reported during the study;",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9953320622444153,
        "detection_dpi": 300
      }
    },
    {
      "id": "96b9e703",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        174.81240844726562,
        2916.509033203125,
        1224.81298828125,
        3141.60302734375
      ],
      "text": "Subjects\n in\n this\n study\n were\n followed\n throughout\n the\n subsequent\nﬂuenza\n season\n (mid\n December\n 2007\n to\n end\n April\n 2008)\n with\neekly\n phone\n calls\n and\n instructed\n to\n return\n to\n the\n study\n clinics\nr\n any\n acute\n respiratory\n illness,\n at\n which\n time\n a\n combined\n nasal\nd\n throat\n swab\n for\n viral\n culture\n was\n obtained.\n The\n primary\n efﬁcacy",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9895095825195312,
        "detection_dpi": 300
      }
    },
    {
      "id": "3d287c62",
      "page_index": 3,
      "role": "Title",
      "bbox": [
        166.03025817871094,
        2836.76611328125,
        519.8609008789062,
        2881.03515625
      ],
      "text": "fﬁ\ny",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.992607593536377,
        "detection_dpi": 300
      }
    },
    {
      "id": "d68f8773",
      "page_index": 3,
      "role": "Title",
      "bbox": [
        166.64576721191406,
        1833.155517578125,
        493.6983947753906,
        1874.3017578125
      ],
      "text": "g\ny",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9810195565223694,
        "detection_dpi": 300
      }
    },
    {
      "id": "57135145",
      "page_index": 3,
      "role": "Title",
      "bbox": [
        169.93338012695312,
        261.3407897949219,
        263.7907409667969,
        294.8177795410156
      ],
      "text": "rum\n hem",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9662250876426697,
        "detection_dpi": 300
      }
    },
    {
      "id": "2a366e2a",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        171.45074462890625,
        841.0599365234375,
        874.0645751953125,
        938.7789306640625
      ],
      "text": "PV\n =\n previously\n vaccinated.\nNPV\n =\n not\n previously\n vaccinated.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9406481385231018,
        "detection_dpi": 300
      }
    },
    {
      "id": "78e0b455",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        162.97203063964844,
        294.9832458496094,
        2442.7666015625,
        335.6463317871094
      ],
      "text": "Group\nN\nPre (day 0) and post vaccination (day 28) geometric mean antibody titer (95% CI) and response rates (95% CI) to the following vaccine antigens",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9291829466819763,
        "detection_dpi": 300
      }
    },
    {
      "id": "4f89769b",
      "page_index": 3,
      "role": "Title",
      "bbox": [
        167.0789794921875,
        182.53366088867188,
        234.2974090576172,
        220.29586791992188
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.5110412240028381,
        "detection_dpi": 300
      }
    },
    {
      "id": "32f16b1d",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        1329.5006103515625,
        259.0006408691406,
        2394.57568359375,
        3145.351806640625
      ],
      "text": "HA0\n vaccine\n produced\n using\n the\n baculovirus\n expression\n system\nn\n healthy\n adults\n [9].  These\n vaccines\n have\n been\n well\n tolerated\n at\n all\noses\n administered,\n and\n are\n associated\n with\n low\n rates\n of\n local\n reac-\nons.\n One\n case\n of\n pericarditis\n was\n detected\n in\n a\n FluBlok\n recipient.\nericarditis\n has\n also\n been\n reported\n previously\n following\n vaccina-\non\n with\n licensed,\n egg-derived\n inﬂuenza\n vaccine\n with\n a\n similar\nme\n course\n [11].\n The\n mechanism\n and\n clinical\n signiﬁcance\n of\n such\nn\n association\n is\n unclear.\nFluBlok\n induced\n serum\n HAI\n antibody\n responses\n to\n all\n three\n vac-\nne\n components\n in\n the\n majority\n of\n recipients,\n and\n the\n lower\n limit\nf\n the\n 95%\n conﬁdence\n interval\n for\n response\n rate\n exceeded\n the\n US\nDA\n criteria\n for\n licensure\n for\n all\n three\n components\n (lower\n limit\n of\nhe\n 95%\n conﬁdence\n interval\n for\n response\n rate\n >40%\n and\n lower\n limit\nf\n the\n 95%\n conﬁdence\n interval\n for\n HAI\n titer\n of\n 1:40\n or\n greater\n >70%)\n2].\nAlthough\n we\n did\n not\n attempt\n to\n verify\n vaccine\n histories\n by\neview\n of\n medical\n records,\n signiﬁcant\n differences\n in\n both\n the\n fre-\nuency\n and\n the\n magnitude\n of\n the\n HAI\n response\n were\n shown\n when\nomparing\n the\n immune\n response\n between\n subjects\n with\n self-\neported\n previous\n vaccination.\n Reduced\n antibody\n response\n rates,\necreased\n post\n vaccination\n titers,\n and\n decreased\n antibody\n secret-\nng\n cell\n responses\n have\n all\n been\n observed\n previously\n in\n adults\n with\nrior\n inﬂuenza\n vaccine\n compared\n to\n those\n without\n [13–16].\n The\nxact\n mechanism\n of\n this\n effect\n remains\n uncertain,\n although\n it\n may\nepresent\n interference\n with\n antigen\n presentation\n by\n pre-existing\nntibody\n [16].\nConsistent\n with\n the\n results\n of\n national\n surveillance\n in\n the\n US\nuring\n the\n 2007–2008\n season\n [17], the\n majority\n of\n inﬂuenza\n A\nruses\n detected\n in\n this\n study\n were\n H3N2\n viruses\n that\n represented\nsubstantial\n antigenic\n mismatch\n with\n the\n vaccine.\n However,\n even\nnder\n these\n circumstances,\n FluBlok\n had\n signiﬁcant\n protective\n efﬁ-\nacy\n against\n culture-conﬁrmed\n inﬂuenza\n illness,\n including\n those\nmeeting\n the\n CDC-ILI\n case\n deﬁnition.\n Inﬂuenza\n B\n viruses\n isolated\n in\nhis\n study\n and\n elsewhere\n in\n North\n America\n during\n the\n 2007–2008\neason\n belonged\n to\n the\n Yamagata\n lineage\n of\n inﬂuenza\n B\n viruses,\ngainst\n which\n vaccines\n representing\n the\n Victoria\n lineage\n would\n be\nxpected\n to\n have\n little\n or\n no\n efﬁcacy.\n We  also\n found\n that\n the\n efﬁ-\nacy\n of\n FluBlok\n against\n CDC-ILI\n associated\n with\n inﬂuenza\n B\n was\nubstantially\n lower\n than\n that\n against\n inﬂuenza\n A.\nComparisons\n \nof\n \nthese\n \nresults\n \nwith\n \nthe\n \nresults\n \nof\n \nother\nssessments\n of\n the\n protective\n efﬁcacy\n of\n inﬂuenza\n vaccines\n are\nomplicated\n by\n differences\n in\n methodologies,\n populations,\n and\nntigenic\n match\n between\n vaccine\n and\n circulating\n strains\n in\n the\npeciﬁc\n year\n that\n studies\n are\n carried\n out.\n Two\n recently\n published\nudies\n have\n evaluated\n egg-grown\n inactivated\n vaccines\n in\n healthy\ndults\n using\n a\n placebo-controlled\n design\n during\n the\n 2007–2008\nnﬂuenza\n season.\n In\n one\n study,\n conducted\n primarily\n in\n Europe,\n the\nverall\n efﬁcacy\n of\n egg-grown\n inactivated\n vaccine\n against\n culture\nonﬁrmed\n illness\n was\n 63%,\n and\n the\n lower\n 95%\n CI\n was\n 46.7%\n [18].\n The\nredominant\n inﬂuenza\n A\n isolates\n in\n that\n study\n were\n H1N1\n viruses,\nwhich\n were\n mostly\n vaccine-like.\n In\n another\n smaller\n study\n done\n on\nollege\n campuses\n in\n Michigan\n [19], the\n protective\n efﬁcacy\n of\n TIV\ngainst\n culture\n conﬁrmed\n illness\n was\n 73%\n (95%\n CI,\n 51%,\n 85%).\n In\nhat\n study,\n 90%\n of\n inﬂuenza\n isolates\n were\n inﬂuenza\n A\n (H3N2),\n but\nhe\n antigenic\n characterization\n of\n isolates\n was\n not\n reported.\n In\n other\necent\n randomized\n trials,\n the\n protective\n efﬁcacy\n of\n TIV\n was\n 22.3%\nn\n the\n 2005–2006\n inﬂuenza\n season\n predominated\n by\n inﬂuenza\n B\nruses\n and\n with\n overall\n low\n attack\n rates\n [20], and\n 49.3%\n over\n two\neasons,\n 2005–2007\n with\n most\n cases\n due\n to\n antigenically\n variant\nruses\n [21].\nBecause\n of\n the\n difﬁculty\n in\n conducting\n placebo-controlled\nudies\n of\n inﬂuenza\n vaccine\n especially\n as\n the\n target\n groups\n for\n vac-\nnation\n have\n expanded,\n several\n recent\n assessments\n of\n inﬂuenza\naccine\n effectiveness\n have\n utilized\n a\n test-negative,\n case–control\nesign.\n Estimates\n of\n overall\n inactivated\n vaccine\n protective\n effec-\nveness\n in\n these\n studies\n have\n ranged\n from\n 10%\n to\n 70%\n [22–25]\n and",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9970771074295044,
        "detection_dpi": 300
      }
    },
    {
      "id": "c2fc83df",
      "page_index": 4,
      "role": "Figure",
      "bbox": [
        247.47889709472656,
        253.6688690185547,
        1238.78515625,
        1633.6221923828125
      ],
      "text": "[FIGURE 1 - See figure_p5_c2fc83df.png]",
      "html": null,
      "image_path": "figures/figure_p5_c2fc83df.png",
      "metadata": {
        "score": 0.9955406785011292,
        "detection_dpi": 300
      }
    },
    {
      "id": "3dd7575f",
      "page_index": 4,
      "role": "Table",
      "bbox": [
        215.25160217285156,
        2586.913330078125,
        1257.26513671875,
        3062.232177734375
      ],
      "text": "[TABLE 8 - See table_p5_3dd7575f.png]",
      "html": null,
      "image_path": "figures/table_p5_3dd7575f.png",
      "metadata": {
        "score": 0.9762725234031677,
        "detection_dpi": 300
      }
    },
    {
      "id": "82c4445e",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        213.456787109375,
        2139.202392578125,
        1265.2095947265625,
        2419.676513671875
      ],
      "text": "In this\n prospective,\n randomized\n clinical\n trial,\n we  evaluated\n the\nfety,\n immunogenicity\n and\n efﬁcacy\n of\n FluBlok,\n a\n trivalent\n recombi-\nant\n hemagglutinin\n (rHA0)\n vaccine.\n The\n vaccine\n was\n well\n tolerated\nhealthy\n adults,\n immunogenic,\n and\n protective\n against\n culture\n con-\nrmed\n inﬂuenza\n illness.\n The\n safety\n data\n generated\n in\n this\n study\ne\n consistent\n with\n the\n safety\n proﬁle\n observed\n in\n other\n studies\n of",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9940598011016846,
        "detection_dpi": 300
      }
    },
    {
      "id": "ec24c40e",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        214.84706115722656,
        1665.939697265625,
        1255.6923828125,
        1779.97509765625
      ],
      "text": "e\n to\n inﬂuenza\n A\n (A)\n and\n inﬂuenza\n B\n (B)\n in\n the\n placebo\n (solid\n line)\n and\n FluBlok\notted\n line)\n groups\n by\n date\n during\n the\n surveillance\n period.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.993809163570404,
        "detection_dpi": 300
      }
    },
    {
      "id": "ad611f31",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        212.1717987060547,
        3065.634521484375,
        1240.226806640625,
        3134.720703125
      ],
      "text": "consecutive\n days.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.992233157157898,
        "detection_dpi": 300
      }
    },
    {
      "id": "75522d49",
      "page_index": 4,
      "role": "Title",
      "bbox": [
        211.79171752929688,
        2061.958984375,
        441.2380065917969,
        2107.843505859375
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9971599578857422,
        "detection_dpi": 300
      }
    },
    {
      "id": "29368d59",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        214.8970489501953,
        1832.8367919921875,
        1275.26025390625,
        2012.4527587890625
      ],
      "text": "curred\n in\n 58/2304\n placebo\n and\n in\n 33/2344\n FluBlok\n recipients\nE\n =\n 44%).\n Overall\n CDC-ILI\n regardless\n of\n culture\n results\n occurred\n in\n62\n (7.0%)\n of\n placebo\n recipients\n and\n 127\n (5.4%)\n of\n FluBlok\n recipients\nr\n an\n efﬁcacy\n of\n 22.9%\n (95%\n CI,\n 2.2%,\n 39.4%)\n against\n this\n outcome.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.97488933801651,
        "detection_dpi": 300
      }
    },
    {
      "id": "4c63df2e",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        222.72193908691406,
        2512.770263671875,
        1264.109619140625,
        2586.5546875
      ],
      "text": "ipients.\nndpoint\nNumber (%) of cases in those receiving\nVaccine efﬁcacy",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9809067845344543,
        "detection_dpi": 300
      }
    },
    {
      "id": "1154c3d2",
      "page_index": 4,
      "role": "Title",
      "bbox": [
        216.36370849609375,
        2477.642333984375,
        311.8004455566406,
        2511.090087890625
      ],
      "text": "tes\n of\n st",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9771054983139038,
        "detection_dpi": 300
      }
    },
    {
      "id": "5541a755",
      "page_index": 5,
      "role": "List",
      "bbox": [
        1285.581298828125,
        720.6351928710938,
        2345.122314453125,
        3096.2041015625
      ],
      "text": "grown\n in\n mammalian\n cells\n or\n embryonated\n eggs.\n J Infect\n Dis\n 1989;160:191–8.\n2]\n Wood\n JM,\n Oxford\n JS,\n Dunleavy\n U,\n Newman\n RW,\n Major\n D,\n Robertson\n JS.\n Inﬂuenza\nA(H1N1)\n vaccine\n efﬁcacy\n in\n animal\n models\n is\n inﬂuenced\n by\n two\n amino\n acid\nsubstitutions\n in\n the\n hemagglutinin\n molecule.\n Virology\n 1989;171:214–21.\n3]  Powers\n DC,\n Smith\n GE,\n Anderson\n EL,\n Kennedy\n DJ,\n Hackett\n CS,\n Wilkinson\n BE,\n et\n al.\nInﬂuenza\n A\n virus\n vaccines\n containing\n puriﬁed\n recombinant\n H3\n hemagglutinin\nare\n well-tolerated\n and\n induce\n protective\n immune\n responses\n in\n healthy\n adults.\nJ\n Infect\n Dis\n 1995;171:1595–8.\n4] Lakey\n DL,\n Treanor\n JJ,\n Betts\n RF,\n Smith\n GE,\n Thompson\n J,\n Sannella\n E,\n et\n al.\n Recom-\nbinant\n baculovirus\n inﬂuenza\n A\n hemagglutinin\n vaccines\n are\n well\n tolerated\n and\nimmunogenic\n in\n healthy\n adults.\n J Infect\n Dis\n 1996;174:838–41.\n5] Treanor\n JJ,\n Betts\n RF,\n Smith\n GE,\n Anderson\n EL,\n Hackett\n CS,\n Wilkinson\n BE,\n et\n al.\n Eval-\nuation\n of\n a\n recombinant\n hemagglutinin\n expressed\n in\n insect\n cells\n as\n an\n inﬂuenza\nvaccine\n in\n young\n and\n elderly\n adults.\n J Infect\n Dis\n 1996;173:1467–70.\n6] Baxter\n R,\n Patriarca\n PA,\n Ensor\n K,\n Izikson\n R,\n Goldenthal\n KL,\n Cox\n MM.\n Reacto-\ngenicity\n and\n immunogenicity\n of\n FluBlok\n trivalent\n recombinant\n baculovirus-\nexpressed\n hemagglutinin\n vaccine\n administered\n intramuscularly\n to\n healthy\nadults\n 50–64\n years\n of\n age.\n Vaccine\n 2011;29:2272–8.\n7]\n Treanor\n JJ,\n Schiff\n GM,\n Couch\n RB,\n Cate\n TR,\n Brady\n RC,\n Hay\n CM,\n et\n al.\n Dose-related\nsafety\n and\n immunogenicity\n of\n a\n trivalent\n baculovirus-expressed\n inﬂuenza-\nvirus\n hemagglutinin\n vaccine\n in\n elderly\n adults.\n J Infect\n Dis\n 2006;193:1223–8.\n8]\n Keitel\n WA,\n Treanor\n J,\n El\n Sahly\n HM,\n Gilbert\n A,\n Maeyer\n AL,\n Patricarca\n PA,\n et\n al.\nComparative\n immunogenicity\n of\n recombinant\n inﬂuenza\n hemagglutinin\n (rHA)\nand  trivalent\n inactivated\n vaccines\n (TIV)\n among\n persons\n >\n 65\n years\n old.\n Vaccine\n2009;28:379–85.\n9] Treanor\n JJ,\n Schiff\n GM,\n Hayden\n FG,\n Brady\n RC,\n Hay\n CM,\n Meyer\n AL,\n et\n al.\n Safety\n and\nimmunogenicity\n of\n a\n baculovirus-expressed\n hemagglutinin\n inﬂuenza\n vaccine:\na  randomized\n controlled\n trial.\n JAMA\n 2007;297:1577–82.\n0] CDC.\n Prevention\n and\n control\n of\n inﬂuenza:\n recommendations\n of\n the\n Advisory\nCommittee\n on\n Immunization\n Practice\n (ACIP),\n 2007.\n MMWR\n Morb\n Mortal\n Wkly\nRep  2007;56:1–40.\n1]\n Meester\n A,\n Luwaert\n R,\n Chaudron\n JM.\n Symptomatic\n pericarditis\n after\n inﬂuenza\nvaccination:\n report\n of\n two\n cases.\n Chest\n 2000;117:1803–5.\n2] FDA.\n Guidance\n for\n industry:\n clinical\n data\n needed\n to\n support\n the\n licensure\n of\nseasonal\n inactivated\n inﬂuenza\n vaccines;\n 2007.\n3]\n Beyer\n WEP,\n Palache\n AM,\n Sprenger\n MJW,\n Hendriksen\n E,\n Tukker\n JJ,\n Darioli\n R,\n et\n al.\nEffects\n of\n repeated\n annual\n inﬂuenza\n vaccination\n on\n vaccine\n sero-response\n in\nyoung and\n elderly\n adults.\n Vaccine\n 1996;14:1331–9.\n4]\n Goodwin\n K,\n Viboud\n C,\n Simonsen\n L.\n Antibody\n response\n to\n inﬂuenza\n vaccination\nin\n the\n elderly:\n a\n quantitative\n review.\n Vaccine\n 2006;24:1159–69.\n5] Engler\n RJ,\n Nelson\n MR,\n Klote\n MM,\n Van\n Raden\n MJ,\n Huang\n CY,\n Cox\n NY,\n et\n al.\n Half-\n vs\nfull-dose\n trivalent\n inactivated\n inﬂuenza\n vaccine\n (2004–2005):\n age,\n dose,\n and\nsex effects\n on\n immune\n responses.\n Arch\n Intern\n Med\n 2008;168:2405–14.\n6]\n Sasaki\n S,\n He\n X-S,\n Holmes\n TH,\n Dekker\n CL,\n Kemble\n GW,\n Arvin\n AM,\n et\n al.\n Inﬂu-\nence\n of\n prior\n inﬂuenza\n vaccination\n on\n antibody\n and\n B-Cell\n responses.\n PLoS\n One\n2008;3:e2975.\n7] CDC.\n Inﬂuenza\n activity—United\n States\n and\n worldwide,\n 2007–08\n season.\n MMWR\nMorb\n Mortal\n Wkly\n Rep\n 2008:57.\n8]\n Frey\n S,\n Vesikari\n T,\n Szymczakiewicz-Multanowska\n A,\n Lattanzi\n M,  Izu\n A,\n Groth\nN,\n et\n al.\n Clinical\n efﬁcacy\n of\n cell\n culture-derived\n and\n egg-derived\n inactivated\nsubunit\n inﬂuenza\n vaccines\n in\n healthy\n adults.\n Clin\n Infect\n Dis\n 2010;51:997–1004.\n9]\n Monto\n AS,\n Ohmit\n SE,\n Petrie\n JG,\n Johnson\n E,\n Truscon\n R,\n Teich\n E,\n et\n al.\n Comparative\nefﬁcacy\n of\n inactivated\n and\n live\n attenuated\n inﬂuenza\n vaccines.\n N\n Engl\n J Med\n2009;361:1260–7.\n0] Beran\n J,\n Wertzova\n V,\n Honegr\n K,\n Kaliskova\n E,\n Havlickova\n M,\n Havlik\n J, et\n al.\nChallenge\n of\n conducting\n a\n placebo-controlled\n randomized\n efﬁcacy\n study\n for\ninﬂuenza\n vaccine\n in\n a\n season\n with\n low\n attack\n rate\n and\n a mismatched\n vaccine\n B\nstrain:\n a\n concrete\n example.\n BMC\n Infect\n Dis\n 2009;9:2.\n1]\n Jackson\n L,\n Gaglani\n M,  Keyserling\n H,\n Balser\n J, Bouveret\n N,\n Fries\n L,\n et\n al.\n Safety,\nefﬁcacy,\n and\n immunogenicity\n of\n an\n inactivated\n inﬂuenza\n vaccine\n in\n healthy\nadults:\n a\n randomized,\n placebo-controlled\n trial\n over\n two\n inﬂuenza\n seasons.\n BMC\nInfect\n Dis\n 2010;10:71–7.\n2]\n Belongia\n EA,\n Kieke\n BA,\n Donahue\n JG,\n Greenlee\n RT,\n Balish\n A,\n Foust\n A,\n et\n al.\nEffectiveness\n of\n inactivated\n inﬂuenza\n vaccines\n varied\n substantially\n with\n anti-\ngenic\n match\n from\n the\n 2004–2005\n season\n to\n the\n 2006–2007\n season.\n J\n Infect\n Dis\n2009:199.\n3]\n Skowronski\n DM,\n Masaro\n C,\n Kwindt\n TL,\n Mak\n A,\n Petric\n M,  Li\n Y,\n et\n al.\n Estimating\nvaccine\n effectiveness\n against\n laboratory-conﬁrmed\n inﬂuenza\n using\n a sentinel\nphysician\n network:\n Results\n from\n the\n 2005–2006\n season\n of\n dual\n A\n and\n B\n vaccine\nmismatch\n in\n Canada.\n Vaccine\n 2007;25:2842–51.\n4]\n Belongia\n E,\n Kieke\n B,\n Coleman\n L,\n Donahue\n J,\n Irving\n S,\n Meece\n J, et\n al.\n Interim\nwithin-season\n estimate\n of\n the\n effectiveness\n of\n trivalent\n inactivated\n inﬂuenza",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9544890522956848,
        "detection_dpi": 300
      }
    },
    {
      "id": "8da0746e",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        169.733154296875,
        1782.26416015625,
        1237.7574462890625,
        3144.033935546875
      ],
      "text": "Study\n sites:\n The\n following\n investigators\n and\n study\n sites\n enrolled\nbjects\n in\n this\n study:\n Mhorag\n Hay\n M.D.,\n University\n of\n Rochester\nhool\n of\n Medicine,\n Rochester,\n NY;\n Mark\n Blatter\n M.D.,\n Primary\nhysicians\n Research,\n Pittsburgh,\n PA;\n Stanley\n Block\n M.D.,\n Kentucky\ndiatric/Adult\n Research,\n Bardstown,\n KY;\n Bruce\n Bowling\n M.D.,\negional\n Clinical\n Research,\n Endwell,\n NY;\n Teresa\n Coats\n M.D.,\n Bench-\nark\n Research,\n Austin,\n TX;\n Hana\n El\n Sahly\n M.D.,\n Baylor\n College\n of\nedicine,\n Houston,\n TX;\n Ivor\n Emanuel\n M.D.,\n Benchmark\n Research,\nn\n Francisco,\n CA;\n Brandon\n Essink\n M.D.,\n Meridian\n Clinical\n Research,\nmaha,\n NB;\n Larry\n Gilderman\n D.O.,\n University\n Clinical\n Research\nmbroke,\n Pines,\n FL;\n Irene\n Graham\n M.D.,\n St.\n Louis\n University,\n St.\nuis,\n MO;\n Matt\n Hall\n M.D.,\n Marshﬁeld\n Clinic,\n Marshﬁeld,\n WI;\n Lydie\nazan\n M.D.,\n Impact\n Clinical\n Trials,\n Beverly\n Hills,\n CA;\n Darrell\n Her-\nngton\n D.O.,\n Benchmark\n Research,\n San\n Angelo,\n TX;\n Steven\n Hull\n.D.,\n Vince\n and\n Associates\n Clinical\n Research,\n Overland\n Park,\n KS;\nobert\n Jeanfreau\n M.D.,\n Benchmark\n Research\n Metairie,\n LA;\n James\nng\n M.D.,\n University\n of\n Maryland,\n Baltimore,\n MD;\n Ivan\n Rarick\n.D.,\n Benchmark\n Research,\n Sacramento,\n CA;\n Keith\n Reisinger\n M.D.,\nimary\n Physicians\n Research,\n Pittsburgh,\n PA;\n Robert\n Rosen\n M.D.,\narolina\n Medical\n Trials,\n Winston-Salem,\n NC;\n Gilbert\n Schiff\n M.D.,\nerling\n Research,\n Cincinnati,\n OH;\n William\n Seger\n M.D.,\n Benchmark\nesearch\n Fort,\n Worth,\n TX;\n Helen\n Keipp\n Talbot\n M.D.,\n Vanderbilt\n Uni-\nrsity,\n Nashville,\n TN;\n Gilbert\n Podolsky\n M.D.,\n Jean\n Brown\n Research\nlt,\n Lake\n City,\n UT;\n Birgit\n Winther\n M.D.,\n University\n of\n Virginia,\n Char-\nttesville,\n VA.\nConﬂict\n of\n interest\n statement:\n J.T.\n has\n received\n grant\n support\n for\nnical\n trials\n from\n Protein\n Sciences\n Corporation,\n Wyeth,\n Sanoﬁ,\naxoSmithKline,\n PaxVax,\n Ligocyte,\n and\n Vaxinnate,\n and\n is\n a\n paid\nnsultant\n to\n ITS\n incorporated\n and\n Novartis.\n H.E.-S.\n has\n received\nant\n support\n from\n GlaxoSmithKline\n for\n clinical\n trials.\n I.G.,\n and\nK.\n report\n no\n conﬂicts\n of\n interest.\n P.P.\n and\n R.K.\n are\n paid\n consul-",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9858109951019287,
        "detection_dpi": 300
      }
    },
    {
      "id": "02dd0ac8",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        154.85748291015625,
        262.80499267578125,
        1231.8731689453125,
        1480.146484375
      ],
      "text": "y\np\ny\ng\nirculating\n viruses,\n with\n highest\n levels\n of\n effectiveness\n reported\n for\nH1\n viruses\n [25]\n and\n lowest\n levels\n for\n inﬂuenza\n B.\nThe\n current\n study\n provides\n evidence\n of\n protective\n efﬁcacy\n of\nbaculovirus-derived\n HA\n vaccine\n in\n adults\n for\n prevention\n of\n sea-\nonal\n inﬂuenza\n and\n supports\n that\n signiﬁcant\n protection\n in\n a\n primed\nopulation\n can\n be\n obtained\n against\n inﬂuenza\n with\n a\n pure\n hemag-\nlutinin\n vaccine.\n The\n efﬁcacy\n results\n also\n demonstrate\n that\n in\ndults,\n the\n minor\n differences\n in\n HA\n glycosylation\n seen\n in\n insect\n cells\nompared\n to\n mammalian\n cells\n and\n the\n synthesis\n of\n the\n HA\n as\n an\nncleaved\n precursor\n do\n not\n preclude\n the\n generation\n of\n an\n effective\nmmune\n response\n in\n adults.\nThe\n use\n of\n recombinant\n DNA\n techniques\n to\n express\n proteins\nn\n cell\n culture\n has\n been\n a\n successful\n approach\n for\n generation\n of\nighly\n effective\n vaccines\n for\n the\n prevention\n of\n hepatitis\n B\n (HBV)\nnd\n human\n papillomavirus\n (HPV),\n and\n baculovirus\n expression\n tech-\nology\n is\n currently\n used\n for\n a\n licensed\n HPV\n vaccine\n [26].\n Among\nhe\n available\n expression\n technologies,\n recombinant\n baculovirus\n is\nspecially\n well\n suited\n for\n production\n of\n inﬂuenza\n vaccine\n because\nhe\n rapidity\n with\n which\n genes\n can\n be\n cloned\n and\n inserted\n into\n this\nector\n facilitates\n updating\n the\n vaccine\n at\n regular\n intervals.\n Expres-\nion\n of\n the\n HA\n protein\n in\n insect\n cells\n using\n recombinant\n baculovirus\nlso\n avoids\n the\n need\n to\n work\n with\n potentially\n pathogenic,\n live\nnﬂuenza\n viruses,\n and\n the\n attendant\n biocontainment\n issues\n that\nwould\n be\n a\n particular\n concern\n for\n production\n of\n pandemic\n vaccines\n27].\n The\n results\n of\n the\n current\n study\n support\n the\n utility\n of\n insect\nells\n for\n the\n production\n of\n well\n tolerated\n and\n effective\n vaccines\n for\neasonal\n inﬂuenza.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9948583841323853,
        "detection_dpi": 300
      }
    },
    {
      "id": "7610bdf4",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        1291.119384765625,
        255.7259521484375,
        2339.33984375,
        532.0717163085938
      ],
      "text": "nts\n to\n Protein\n Sciences\n and\n multiple\n other\n entities.\n R.I.\n and\n M.C.\ne\n employees\n of\n Protein\n Sciences.\n Financial\n support: The\n study\nas\n funded\n by\n Protein\n Sciences\n Corporation,\n the\n manufacturers\nthe\n vaccine.\n Protein\n Sciences\n Corporation\n also\n funded\n ICON\n as\ne\n CRO\n for\n the\n study\n and\n Ockham\n which\n performed\n the\n data\nnalysis.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9850819110870361,
        "detection_dpi": 300
      }
    },
    {
      "id": "6e84399f",
      "page_index": 5,
      "role": "Title",
      "bbox": [
        165.18035888671875,
        1574.3701171875,
        500.52642822265625,
        1615.758056640625
      ],
      "text": "g",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9964577555656433,
        "detection_dpi": 300
      }
    },
    {
      "id": "b45d62a5",
      "page_index": 5,
      "role": "Title",
      "bbox": [
        1289.19677734375,
        632.4609985351562,
        1474.6937255859375,
        671.756591796875
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9909530878067017,
        "detection_dpi": 300
      }
    },
    {
      "id": "14ad8492",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        172.49472045898438,
        1656.9395751953125,
        1219.652587890625,
        1764.5911865234375
      ],
      "text": "g\ny\ng\n,\nFleur,\n Anthony\n Meyer\n and\n Adam\n Gilbert,\n and\n the\n effort\n of\n inves-\ngators\n at\n the\n study\n sites\n listed\n below.\nSt d\nit\nTh f ll\ni\ni\nti\nt\nd t d\nit\nll d",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9709224700927734,
        "detection_dpi": 300
      }
    },
    {
      "id": "102671d1",
      "page_index": 6,
      "role": "List",
      "bbox": [
        228.23049926757812,
        266.54425048828125,
        1300.09814453125,
        468.5509338378906
      ],
      "text": "Mortal\n Wkly\n Rep\n 2008;57:393–8.\nSkowronski\n DM,\n De\n Serres\n G,\n Dickinson\n J,\n Petric\n M,\n Mak\n A,\n Fonseca\n K,\n et\n al.\nComponent-speciﬁc\n effectiveness\n of\n trivalent\n inﬂuenza\n vaccine\n as\n monitored\nthrough\n a\n sentinel\n surveillance\n network\n in\n Canada,\n 2006–2007.\n J\n Infect\n Dis\n2009;199:160–79.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.9482018351554871,
        "detection_dpi": 300
      }
    },
    {
      "id": "e4865ade",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        1338.6959228515625,
        263.8220520019531,
        2383.609375,
        474.8043518066406
      ],
      "text": "]\np\nJ\nEfﬁcacy\n of\n a\n bivalent\n L1\n virus-like\n particle\n vaccine\n in\n prevention\n of\n infection\nwith human\n papillomavirus\n types\n 16\n and\n 18\n in\n young\n women:\n a\n randomised\ncontrolled\n trial.\n Lancet\n 2004;364:1757–65.\n]\n Treanor\n JJ.\n Recombinant\n proteins\n produced\n in\n insect\n cells.\n Curr\n Top\n Microbiol\nImmunol\n 2009;333:211–25.",
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.8462008237838745,
        "detection_dpi": 300
      }
    },
    {
      "id": "da484fd2",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        997.5639038085938,
        181.78611755371094,
        1590.37841796875,
        218.98777770996094
      ],
      "text": null,
      "html": null,
      "image_path": null,
      "metadata": {
        "score": 0.7165219783782959,
        "detection_dpi": 300
      }
    }
  ],
  "metadata": {
    "detection_dpi": 300,
    "total_pages": 7,
    "merge_settings": {
      "merge_overlapping": true,
      "merge_threshold": 0.1,
      "confidence_weight": 0.7,
      "area_weight": 0.3
    },
    "extraction": {
      "text_blocks": 56,
      "figure_blocks": 6,
      "figures_dir": "/Users/saul/projects/solstice/solstice/data/cache/Treanor_et_al.__2011_/extracted/figures"
    }
  },
  "reading_order": [
    [
      "e895b74d",
      "8f330827",
      "776faf31",
      "d565acf9",
      "393e8d7c",
      "6568da35",
      "041d051e",
      "18697bc8",
      "eecb34ce",
      "0a86f0f1",
      "6d743ec2",
      "e126e7cc"
    ],
    [
      "b1cafa15",
      "9bd380aa",
      "6407097a",
      "57b7169e",
      "081c4cc9",
      "aaa92306",
      "bd12cc22",
      "c767ff20",
      "253719be",
      "e0130593",
      "01e433fe",
      "39d5e393",
      "07b850a1",
      "4c739f9d"
    ],
    [
      "6a79c2aa",
      "8a2a1e60",
      "5bbb19f2",
      "c712d5fe",
      "718e89cb",
      "402f2b92",
      "75d5bc70",
      "0d504bc4",
      "8051b61b",
      "e24f87e5",
      "9e027617",
      "fda05911",
      "9fb6598a",
      "83dd9191"
    ],
    [
      "4f89769b",
      "57135145",
      "78e0b455",
      "eeb10c0d",
      "2a366e2a",
      "e5b59852",
      "4073a174",
      "d68f8773",
      "a1d79ae0",
      "3d287c62",
      "96b9e703",
      "12d470c9"
    ],
    [
      "c2fc83df",
      "ec24c40e",
      "29368d59",
      "75522d49",
      "82c4445e",
      "1154c3d2",
      "4c63df2e",
      "3dd7575f",
      "ad611f31",
      "32f16b1d"
    ],
    [
      "02dd0ac8",
      "6e84399f",
      "14ad8492",
      "8da0746e",
      "7610bdf4",
      "b45d62a5",
      "5541a755"
    ],
    [
      "da484fd2",
      "102671d1",
      "e4865ade"
    ]
  ]
}